ParcelBio
YC W24Elevated mRNA for transformative medicines.
San Francisco, CA, USAFounded 20246 employeesparcelbio.com
Team
6
Founded
2024
About
ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform uses novel RNA domains to enhance protein expression and extend activity, enabling therapies that reach the thresholds required for meaningful, and potentially curative, clinical outcomes. The company is advancing programs in autoimmune disease, oncology, and encoded protein therapeutics.
Tags
Gene Therapy Synthetic Biology Biotech Therapeutics Drug discovery Healthcare
No open roles at this time.
Similar Healthcare startups
Granza Bio
Building programmable therapeutics for the immune system
Synthetic BiologyBiotechHealthcare
Open Jobs —
Team 7
Founded 2024
Velorum Therapeutics
Breakthrough medicines unlocking the biology of heme
BiotechHealthcareTherapeutics
Open Jobs —
Team 5
Founded 2024
Aidy
Mobile app helping people better manage chronic health conditions
Consumer Health ServicesDigital Health
Open Jobs —
Team 2
Founded 2024
Andy AI
Faster clinical documentation for home health nurses
Artificial IntelligenceSaaSHealth Tech
Open Jobs —
Team 5
Founded 2024